Company: ALIT
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001809104-25-000159
Chunk: 44

Company: Alight, Inc. / Delaware
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 44
---
 Kausik Rajgopal Robert A. Schriesheim

| Proxy Statement andMeeting Overview |     | Board ofDirectors |     | CorporateGovernance |     | ExecutiveCompensation |     | AuditorApprovals |     | Say-On-Pay |     | AdditionalInformation |

34 2025 PROXY STATEMENT Nominating and Corporate Governance Committee All members of the Nominating and Corporate Committee have been determined to be “independent” under NYSE listing standards applicable to board of directors in general. The Nominating and Corporate Governance Committee is responsible for, among other things: • identifying, evaluating, and selecting, or making recommendations to the Board regarding, nominees for election to the Board and its committees; • evaluating the performance of the Board and of individual directors; • considering, and making recommendations to the Board regarding the composition of the Board and its committees; • overseeing succession planning for management; • reviewing developments in corporate governance practices, including related to environmental, social and governance matters; • evaluating the adequacy of the corporate governance practices and reporting; and • developing, and making recommendations to the Board regarding, corporate governance guidelines and matters. The Board has adopted a written charter for the Nominating and Corporate Governance Committee, which is available on the Company’s website at investor.alight.com. Kausik Rajgopal (Chair) Richard N. Massey Coretha M. Rushing 2024 Meetings 7 Siobhan Nolan Mangini William P. Foley, II Robert A. Lopes, Jr.

| Proxy Statement andMeeting Overview |     | Board ofDirectors |     | CorporateGovernance |     | ExecutiveCompensation |     | AuditorApprovals |     | Say-On-Pay |     | AdditionalInformation |

| 35 |

Board and Committee Meetings; Attendance Directors are encouraged to attend our annual meetings of stockholders and, at our 2024 annual meeting of stockholders, ten of our eleven directors at the time attended the meeting. During the year ended December 31, 2024, the Board held thirty-one meetings, the Audit Committee held eight meetings, the Compensation Committee met seven times and the Nominating and Corporate Governance Committee met seven times. In 2024, all of our incumbent directors attended at least 75% of the meetings of the Board and committees during the time in which he or she served as a member of the Board or such committee , other than Ms. Williams, who attended 71% of the meetings of the Board and committees during the time in which